Bruce Springsteen, in a trailer for an upcoming ABC News special, shared his thoughts into wife Patti Scialfa’s cancer battle after she revealed last month that she was diagnosed with multiple myeloma ...

4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.

Morgan Stanley notes that Gilead (GILD) and Arcellx’s (ACLX) anito-cel, a BCMA-directed CAR-T therapy in development for relapsed / ...

Looking back, I realise there were all sorts of symptoms there. But after I went skiing, I felt I was having a heart attack" ...

Needham raised the firm’s price target on Arcellx (ACLX) to $96 from $81 and keeps a Buy rating on the shares. The firm updated its ...

Following the FDA's green light for a combo regimen of Sanofi’s Sarclisa in patients with newly diagnosed multiple myeloma last week, J&J has wasted little time hitting back with new data on its ...

Bruce Springsteen revealed how Patti Scialfa is managing her health after publicly revealing her diagnosis last month ...

And last month we learned that Springsteen’s wife (and member of the E Street Band), Patti Scialfa, has been living for years with multiple myeloma since her 2018 diagnosis. Scialfa, 71 ...

Speakers on precursor disease addressed distinctions between MGUS and smoldering multiple myeloma, risk stratification, and new thinking on the role of immunological aging, especially how it affec ...

Saad Z. Usmani, MD, MBA, FACP, FASCO, discusses the safety data from the phase 3 CEPHEUS trial in newly diagnosed multiple ...

Safety and Efficacy of Standard of Care Ciltacabtagene Autoleucel for Relapsed/Refractory Multiple Myeloma. Blood Journal , 2024; DOI: 10.1182/blood.2024025945 Cite This Page : ...

First, blood cancers are far more common than you might think: One person in the United States is diagnosed with a blood cancer, including leukemia, lymphoma or myeloma, every three minutes.